Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diltiazem in Jervell and Lange-Nielsen Syndrome
NCT06534671Phase 4Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Oct 2024
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of diltiazem in Jervell and Lange-Nielsen syndrome (JLNS), sponsored by Vanderbilt University Medical Center. Started Oct 2024; status: completed.
02
Drugs
diltiazem
03
Conditions
Jervell and Lange-Nielsen syndrome (JLNS)
Beyond the preview
Go deeper on NCT06534671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06534671.